Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Il‐Chi Chang"'
Autor:
Yu‐Ting Wang, Il‐Chi Chang, Chih‐Yi Chen, Jiun‐Yi Hsia, Frank Cheau‐Feng Lin, Wan‐Ru Chao, Tuan‐Ying Ke, Ya‐Ting Chen, Chih‐Jung Chen, Min‐Shu Hsieh, Shiu‐Feng Huang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 6, Pp 592-601 (2023)
Abstract Background The eighth edition of the American Joint Committee on Cancer (AJCC) staging system for lung cancer adopts new criteria for tumor size, and for determining pTis, pT1a(mi), and pT1a. The latter is based on the size of stromal invasi
Externí odkaz:
https://doaj.org/article/0ff50e5972c44e84be8e43b876405b44
Autor:
Kuei-Min Chung, Ya-Ting Chen, Chih-Chen Hong, Il-Chi Chang, Si-Ying Lin, Li-Yu Liang, Yi-Rong Chen, Chau-Ting Yeh, Shiu-Feng Huang
Publikováno v:
Biochemistry and Biophysics Reports, Vol 31, Iss , Pp 101303- (2022)
Hepatocellular carcinoma (HCC) is the main threat for the patients infected with hepatitis B virus (HBV), but the oncogenic mechanism of HBV-related HCC is still controversial. Previously, we have found that several HBV surface gene (HBS) non-sense m
Externí odkaz:
https://doaj.org/article/3323f4ea14ca48028794cf0c9efb7f72
Autor:
Shih-Chiang Huang, Shiu-Feng Huang, Ya-Ting Chen, Yu Chang, Yu-Ting Chiu, Il-Chi Chang, Hong-Dar Isaac Wu, Jinn-Shiun Chen
Publikováno v:
Biomedical Journal, Vol 40, Iss 1, Pp 39-48 (2017)
Background: The outcome of colon cancer patients without lymph node metastasis is heterogeneous. Searching for new prognostic markers is warranted. Methods: One hundred twenty stage I–II colon cancer patients who received complete surgical excision
Externí odkaz:
https://doaj.org/article/df23f1623f55406aa4db015bb1e15915
Autor:
John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, Chih-Hung Chen, Kun-Yun Yeh, Li-Ying Ou, Chia-Hsun Hsieh, Hong-Dar Isaac Wu, Ying-Tsong Chen, Il-Chi Chang, Shiu-Feng Huang
Publikováno v:
Biomedical Journal, Vol 38, Iss 3, Pp 221-228 (2015)
Background: The time schedules for response evaluation of epidermal growth factor receptor-tyrosine kinase Inhibitor (EGFR-TKI) in non-small cell lung cancer (NSCLC) patients are still ill-defined. Methods: Stage IIIB/IV patients with histologically
Externí odkaz:
https://doaj.org/article/173c658af2ba477082f7a463f7862dea
Autor:
Shiu-Feng Huang, Ya-Ting Chen, Wei-Chen Lee, Il-Chi Chang, Yu-Ting Chiu, Yu Chang, Hsiao-Chen Tu, Chiou-Hwa Yuh, Isao Matsuura, Liang-Yu Shih, Ming-Wei Lai, Hong-Dar Isaac Wu, Miin-Fu Chen, Chau-Ting Yeh
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89753 (2014)
BACKGROUND & AIMS: The correlation between chronic hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) has been well-established. But the roles of viral factor remain uncertain. Only HBV X gene and nonsense mutations of S gene (C-ter
Externí odkaz:
https://doaj.org/article/55ddc199bd37473daea885c41b59eae5
Autor:
Yi-Cheng Wu, Il-Chi Chang, Chi-Liang Wang, Tai-Di Chen, Ya-Ting Chen, Hui-Ping Liu, Yen Chu, Yu-Ting Chiu, Tzu-Hua Wu, Li-Hui Chou, Yi-Rong Chen, Shiu-Feng Huang
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70839 (2013)
Recently Echinoderm microtubule-associated protein-like 4- anaplastic lymphoma kinase (EML4-ALK) fusion gene has become an important biomarker for ALK tyrosine kinase inhibitor (crizotinib) treatment in NSCLC. However, the best detection method and t
Externí odkaz:
https://doaj.org/article/b02b43ef58fe4ec1b742720ed9ecc510
Autor:
Yu‐Ting Wang, Il‐Chi Chang, Chih‐Yi Chen, Jiun‐Yi Hsia, Frank Cheau‐Feng Lin, Wan‐Ru Chao, Tuan‐Ying Ke, Ya‐Ting Chen, Chih‐Jung Chen, Min‐Shu Hsieh, Shiu‐Feng Huang
Publikováno v:
Thoracic Cancer. 14:592-601
The eighth edition of the American Joint Committee on Cancer (AJCC) staging system for lung cancer adopts new criteria for tumor size, and for determining pTis, pT1a(mi), and pT1a. The latter is based on the size of stromal invasion. It is quite chal
Autor:
Saravana R. K. Murthy, Xuyu Yang, Yu Chang, Shiu-Feng Huang, Yu-Ting Chiu, Ya-Ting Chen, Il-Chi Chang, Y. Peng Loh, Hong-Dar Isaac Wu
Publikováno v:
Tumor Biology. 37:9745-9753
Tumor recurrence and metastasis are the major causes of death for hepatocellular carcinoma (HCC) patients who are able to receive curative resection. Identifying the predicting biomarkers for tumor recurrence would improve their survival. RNA extract
Autor:
Cheng-Chung Tsai, Chih-Chen Hong, Yung-Ming Jeng, Shiu-Feng Huang, Il-Chi Chang, Cheng-Chung Wu, Hock-Liew Eng, Chao-Long Chen, Ming-Chih Ho, John Wang, Chi-Ling Chen, Hui-Hwa Tseng, Ying-Ying Shen, Tseng-Chang Yen, Yun-Fan Liaw, Hsien-Chung Yu, Chau-Ting Yeh, Wei-Chen Lee, Pei-Jer Chen
Publikováno v:
Hepatology Communications
Metabolic risk factors, such as obesity, fatty liver, high lipidemia, and diabetes mellitus are associated with increased risk for nonviral hepatocellular carcinoma (HCC); however, few nonviral HCC studies have stratified patients according to underl
Autor:
Yu-Ting Chiu, Shih-Chiang Huang, Yu Chang, Jinn-Shiun Chen, Shiu-Feng Huang, Ya-Ting Chen, Il-Chi Chang, Hong-Dar Isaac Wu
Publikováno v:
Biomedical Journal, Vol 40, Iss 1, Pp 39-48 (2017)
Background The outcome of colon cancer patients without lymph node metastasis is heterogeneous. Searching for new prognostic markers is warranted. Methods One hundred twenty stage I–II colon cancer patients who received complete surgical excision d